The oncogenic fusion protein DNAJB1-PRKACA can be actively targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma

被引：0

作者：

Bauer, Jens ^{[1
]}

Kohler, Natalie ^{[2
]}

Maringer, Yacine ^{[1
]}

Bucher, Philip ^{[3
]}

Bilich, Tatjana ^{[1
]}

Zwick, Melissa ^{[2
]}

Dicks, Severin ^{[4
]}

Nelde, Annika ^{[1
]}

Dubbelaar, Marissa ^{[1
]}

Scheid, Jonas ^{[1
]}

Wacker, Marcel ^{[1
]}

Heitmann, Jonas J. ^{[1
]}

Schroeder, Sarah ^{[1
]}

Rieth, Jonas ^{[1
]}

Denk, Monika ^{[5
]}

Richter, Marion ^{[5
]}

Klein, Reinhild ^{[1
]}

Bonzheim, Irina ^{[1
]}

Luibrand, Julia ^{[1
]}

Holzer, Ursula ^{[3
]}

Ebinger, Martin ^{[3
]}

Brecht, Ines B. ^{[3
]}

Bitzer, Michael ^{[1
]}

Boerries, Melanie ^{[4
]}

Salih, Helmut R. ^{[1
]}

Rammensee, Hans-Georg ^{[5
]}

Hailfinger, Stephan ^{[6
]}

Walz, Juliane S. ^{[1
]}

机构：

[1] Univ Tubingen Hosp, Tubingen, Germany

[2] Albert Ludwigs Univ, Freiburg, Germany

[3] Univ Childrens Hosp, Tubingen, Germany

[4] Univ Freiburg, Freiburg, Germany

[5] Univ Tubingen, Tubingen, Germany

[6] Univ Hosp Munster, Munster, Germany

来源：

CANCER RESEARCH | 2022年 / 82卷 / 12期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

2008

引用

页数：2

共 50 条

[31] DNAJB1-PRKACA fusion protein-regulated LINC00473 promotes tumor growth and alters mitochondrial fitness in fibrolamellar carcinoma
Ma, Rosanna K.
Tsai, Pei-Yin
Farghli, Alaa R.
Shumway, Alexandria
Kanke, Matt
Gordan, John D.
Gujral, Taranjit S.
Vakili, Khashayar
Nukaya, Manabu
Noetzli, Leila
Ronnekleiv-Kelly, Sean
Broom, Wendy
Barrow, Joeva
Sethupathy, Praveen
PLOS GENETICS, 2024, 20 (03):
[32] NMR Mapping of the Allosteric Network in the Oncogenic Protein Kinase A Chimera Dnajb1-PRKACA
Karamafrooz, Adak N.
Li, Geoffrey N.
Simon, Sanford M.
Taylor, Susan S.
Veglia, Gianluigi N.
FASEB JOURNAL, 2017, 31
[33] Integrated Phosphoproteomics for Identifying Substrates of Human Protein Kinase A (PRKACA) and Its Oncogenic Mutant DNAJB1-PRKACA
Karamafrooz, Adak
Brennan, Jack
Thomas, David D.
Parker, Laurie L.
JOURNAL OF PROTEOME RESEARCH, 2021, 20 (10) : 4815 - 4830
[34] FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion
Hackenbruch, Christopher
Bauer, Jens
Heitmann, Jonas S.
Maringer, Yacine
Nelde, Annika
Denk, Monika
Zieschang, Lisa
Kammer, Christine
Federmann, Birgit
Jung, Susanne
Martus, Peter
Malek, Nisar P.
Nikolaou, Konstantin
Salih, Helmut R.
Bitzer, Michael
Walz, Juliane S.
FRONTIERS IN ONCOLOGY, 2024, 14
[35] CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma
Engelholm, Lars H.
Riaz, Anjum
Serra, Denise
Dagnaes-Hansen, Frederik
Johansen, Jens V.
Santoni-Rugiu, Eric
Hansen, Steen H.
Niola, Francesco
Froedin, Morten
GASTROENTEROLOGY, 2017, 153 (06) : 1662 - +
[36] FusionVAC22_01: A phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion
Hackenbruch, C.
Bauer, J.
Heitmann, J. S.
Maringer, Y.
Nelde, A.
Federmann, B.
Bitzer, M.
Salih, H. R.
Walz, J. S.
ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 127 - 127
[37] A Unique Group of Fibrolamellar Carcinomas Lack the Classic DNAJB1-PRKACA Fusion and Instead Have PRKAR1A Loss
Graham, Rondell
Lackner, Karoline
Terracciano, Luigi
Gonzalez-Cantu, Yessica
Maleszewski, Joseph J.
Greipp, Patricia T.
Torbenson, Michael S.
LABORATORY INVESTIGATION, 2017, 97 : 417A - 417A
[38] FusionVAC22_01: A phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion.
Bitzer, Michael
Hackenbruch, Christopher
Bauer, Jens
Heitmann, Jonas S.
Maringer, Yacine
Nelde, Annika
Salih, Helmut R.
Walz, Juliane S.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : TPS580 - TPS580
[39] Conformational Landscape of the PRKACA-DNAJB1 Chimeric Kinase, the Driver for Fibrolamellar Hepatocellular Carcinoma
Michael D. Tomasini
Yingjie Wang
Adak Karamafrooz
Geoffrey Li
Thijs Beuming
Jiali Gao
Susan S. Taylor
Gianluigi Veglia
Sanford M. Simon
Scientific Reports, 8
[40] FusionVAC22_01: A phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion.
Heitmann, Jonas S.
Bitzer, Michael
Hackenbruch, Christopher
Bauer, Jens
Maringer, Yacine
Nelde, Annika
Salih, Helmut R.
Walz, Juliane S.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)

← 1 2 3 4 5 →